Cre-GFP Adeno-associated virus(AAV Serotype 1)

AAV is a small, non-enveloped virus with a single-stranded DNA genome that belongs to the Parvoviridae family. They are considered non-pathogenic to humans, which makes them particularly suitable for use as gene therapy vectors. Like other AAV serotypes, AAV1 has a unique capsid protein structure that affects its tropism (the cells it can effectively infect) and its overall efficiency as a gene therapy vector. AAV1 has been identified as having a high affinity for skeletal muscle tissue, which makes it a candidate for the treatment of muscle diseases. Its ability to effectively transduce muscle cells has made it a research priority for genetic diseases that affect muscle function, such as Duchenne muscular dystrophy.

Cre-GFP AAV1 is a powerful tool in molecular genetics and neuroscience. This recombinant viral vector combines the Cre-lox recombination system with a reporter gene encoding GFP (green fluorescent protein), providing a versatile method for targeted gene manipulation and visualization in vivo. The Cre-lox system promotes site-specific recombination, allowing for precise gene modification. When the target genome contains loxP sites flanking specific regions, the Cre recombinase introduced by AAV can excise, invert, or translocate DNA fragments at these sites. This ability to selectively manipulate genes is essential for creating conditional knockout models or activating or silencing genes in specific tissues or developmental stages.